Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,910	2,819	2,067	2,332	2,296	1,488
Other Revenue	138.84	138.84	47.17	108.67	67.67	9.49
Revenue	3,049	2,958	2,114	2,441	2,363	1,497
Revenue Growth (YoY)	32.96%	39.91%	-13.39%	3.28%	57.86%	-21.87%
Cost of Revenue	2,148	2,121	1,535	1,612	1,526	808.77
Gross Profit	901.02	836.44	579.23	829.2	837.21	688.42
Selling, General & Admin	223.13	222	221.61	232.28	175.11	143.25
Research & Development	249.11	233.34	189.13	187.71	133.53	84.3
Other Operating Expenses	10.26	13.83	9.21	-4.09	22.94	10.45
Operating Expenses	487.55	472.51	413.68	422.59	337.95	241.23
Operating Income	413.47	363.93	165.55	406.61	499.25	447.19
Interest Expense	-24.5	-27.43	-32.17	-20.01	-16.29	-3.86
Interest & Investment Income	146.28	160.75	219.77	236.78	229.61	52.18
Earnings From Equity Investments	-9.9	-8.95	-7.82	-3.71	-	-
Currency Exchange Gain (Loss)	36.73	36.73	29.59	82.97	-14.14	-18.26
Other Non Operating Income (Expenses)	-10.32	-6.04	-5.7	-4.61	-0.59	-0.32
EBT Excluding Unusual Items	551.75	518.99	369.22	698.03	697.84	476.93
Gain (Loss) on Sale of Investments	-	-	-	-	-	9.15
Gain (Loss) on Sale of Assets	0.4	0.42	-0.01	0.07	-	-
Asset Writedown	5.07	-0.05	-0.26	-0.02	-0.06	-1.15
Other Unusual Items	25.03	28.66	79.97	-2.09	26.66	35.85
Pretax Income	582.26	548.02	448.92	695.99	724.45	520.79
Income Tax Expense	90.21	73.43	40.39	83.34	90.94	63.45
Earnings From Continuing Operations	492.05	474.59	408.54	612.65	633.51	457.34
Minority Interest in Earnings	28.6	14.37	-42.01	-59.39	-38.79	0.33
Net Income	520.65	488.96	366.52	553.27	594.72	457.67
Net Income to Common	520.65	488.96	366.52	553.27	594.72	457.67
Net Income Growth	25.66%	33.41%	-33.75%	-6.97%	29.94%	-4.43%
Shares Outstanding (Basic)	585	582	582	582	583	543
Shares Outstanding (Diluted)	585	582	582	582	583	543
Shares Change (YoY)	0.07%	0.05%	-0.10%	-0.11%	7.38%	6.91%
EPS (Basic)	0.89	0.84	0.63	0.95	1.02	0.84
EPS (Diluted)	0.89	0.84	0.63	0.95	1.02	0.84
EPS Growth	25.57%	33.33%	-33.68%	-6.86%	21.01%	-10.61%
Free Cash Flow	33.33	-22.38	-1,000	-3,395	-880.49	-248.15
Free Cash Flow Per Share	0.06	-0.04	-1.72	-5.83	-1.51	-0.46
Dividend Per Share	0.400	0.400	0.190	0.180	0.321	0.571
Dividend Growth	110.53%	110.53%	5.56%	-43.99%	-43.75%	-
Gross Margin	29.55%	28.28%	27.40%	33.97%	35.42%	45.98%
Operating Margin	13.56%	12.30%	7.83%	16.66%	21.12%	29.87%
Profit Margin	17.08%	16.53%	17.34%	22.66%	25.16%	30.57%
Free Cash Flow Margin	1.09%	-0.76%	-47.32%	-139.06%	-37.25%	-16.57%
EBITDA	736.94	679.85	451.26	671.73	667.79	565.51
EBITDA Margin	24.17%	22.98%	21.34%	27.52%	28.25%	37.77%
D&A For EBITDA	323.47	315.92	285.72	265.12	168.54	118.32
EBIT	413.47	363.93	165.55	406.61	499.25	447.19
EBIT Margin	13.56%	12.30%	7.83%	16.66%	21.12%	29.87%
Effective Tax Rate	15.49%	13.40%	9.00%	11.97%	12.55%	12.18%
Revenue as Reported	3,049	2,958	2,114	2,441	2,363	1,497

Source: S&P Global Market Intelligence. Standard template. Financial Sources.